Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Odonate Inc ODTC

Healthcare
Odonate, Inc., formerly Odonate Therapeutics, Inc., is a pharmaceutical company. The Company is focused on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The Company is no longer in development of tesetax.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (PINL:ODTC)

Grabar Law Office Investigates Potential Claims Against Officers and Directors of Odonate Therapeutics, Inc. After an Agreement to Settle Class Action for $12.5 Million

Newsfile May 26, 2022

Grabar Law Office Investigates Potential Claims Against Officers and Directors of Odonate Therapeutics, Inc. After an Agreement Is Reached to Settle Class Action

Newsfile May 10, 2022

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Odonate Therapeutics, Inc.

Newsfile April 19, 2022

Odonate Announces Expected Delisting of Its Stock

Business Wire January 7, 2022

ODONATE INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Odonate Therapeutics, Inc. - ODT

PR Newswire December 10, 2021

Odonate Therapeutics Announces Planned Return of Capital to Stockholders through Share Repurchase Plan

Business Wire November 17, 2021

Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021

Business Wire November 10, 2021

ODONATE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Odonate Therapeutics, Inc. - ODT

Business Wire August 20, 2021

SHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investigation for Possible False Statements to Investors

PR Newswire August 13, 2021
View More News ››

Opinion & Analysis (PINL:ODTC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:ODTC)

Be the first to post on this bullboard.

JZR Gold Inc.

JZR Gold Inc.

JZR Gold Inc. is a Canada-based junior mining resource company. The Company is engaged in the business of the exploration and ...
View More »